Back to Search
Start Over
Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect.
- Source :
-
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2020 Oct 01; Vol. 75 (10), pp. 3084-3086. - Publication Year :
- 2020
- Subjects :
- Adult
Aged
Aged, 80 and over
COVID-19
Coronavirus Infections drug therapy
Cytochrome P-450 CYP3A Inhibitors administration & dosage
Drug Therapy, Combination
Female
Humans
Lopinavir administration & dosage
Male
Middle Aged
Pandemics
Pneumonia, Viral drug therapy
Ritonavir administration & dosage
SARS-CoV-2
Time Factors
Withholding Treatment trends
Young Adult
Betacoronavirus
Coronavirus Infections metabolism
Cytochrome P-450 CYP3A Inhibitors metabolism
Drug Interactions physiology
Lopinavir metabolism
Pneumonia, Viral metabolism
Ritonavir metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1460-2091
- Volume :
- 75
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- The Journal of antimicrobial chemotherapy
- Publication Type :
- Report
- Accession number :
- 32556272
- Full Text :
- https://doi.org/10.1093/jac/dkaa253